Helius Medical Technologies Inc (HSDT)
2.66
-0.94
(-26.11%)
USD |
NASDAQ |
May 02, 16:00
3.54
+0.88
(+33.08%)
Pre-Market: 09:14
Helius Medical Technologies Cash from Investing (Quarterly): -0.003M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.003M |
| September 30, 2023 | -0.006M |
| June 30, 2023 | -0.001M |
| March 31, 2023 | -0.019M |
| December 31, 2022 | 0.002M |
| September 30, 2022 | -0.007M |
| June 30, 2022 | -0.01M |
| March 31, 2022 | 0.004M |
| December 31, 2021 | -0.005M |
| September 30, 2021 | -0.03M |
| June 30, 2021 | 0.00 |
| March 31, 2021 | -0.021M |
| December 31, 2020 | -0.049M |
| September 30, 2020 | -0.011M |
| June 30, 2020 | 0.061M |
| March 31, 2020 | -0.01M |
| December 31, 2019 | -0.509M |
| September 30, 2019 | -0.056M |
| June 30, 2019 | -0.043M |
| March 31, 2019 | -0.161M |
| December 31, 2018 | -0.015M |
| Date | Value |
|---|---|
| September 30, 2018 | -0.226M |
| June 30, 2018 | -0.172M |
| March 31, 2018 | -0.027M |
| December 31, 2017 | -0.009M |
| September 30, 2017 | -0.066M |
| June 30, 2017 | -0.115M |
| March 31, 2017 | |
| September 30, 2016 | |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.378M |
| March 31, 2015 | -0.378M |
| December 31, 2014 | -0.1739M |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.1739M |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-0.509M
Minimum
Dec 2019
0.061M
Maximum
Jun 2020
-0.0375M
Average
-0.01M
Median
Mar 2020
Cash from Investing (Quarterly) Benchmarks
| ARCA biopharma Inc | 0.00 |
| Cerus Corp | 8.216M |
| NeuroOne Medical Technologies Corp | -0.0371M |
| Perspective Therapeutics Inc | -0.089M |
| Electromed Inc | -0.087M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.034M |
| Cash from Financing (Quarterly) | 0.622M |
| Free Cash Flow | -10.44M |
| Free Cash Flow Per Share (Quarterly) | -2.870 |
| Free Cash Flow to Equity (Quarterly) | -2.037M |
| Free Cash Flow to Firm (Quarterly) | -2.037M |
| Free Cash Flow Yield | -626.7% |